수술 시뮬레이션 시장 규모, 점유율, 동향 분석 보고서 : 전문분야별, 재료별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Surgical Simulation Market Growth & Trends:

The global surgical simulation market size is expected to reach USD 1,134.1 million by 2030, registering a CAGR of 16.40% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising preference for minimally invasive surgical procedures, increasing focus on patient safety, and growing geriatric population are boosting the market growth. With the growing geriatric population, the problem of surgery for these patients has become increasingly important. With the constant aging population, there arises a need for technology-driven surgical simulation to help avoid or diminish medical errors during surgeries, which, in turn, is contributing to the market growth.

During the COVID-19 pandemic, VirtaMed occupied their simulators on 'tour' frequent times to support continuing medical education and supply workshops for residents across France, Switzerland, and Germany. In February 2021, the company started its third tour and training initiative in Berlin with the German Knee Society. In addition, during the pandemic, elective surgeries halted, which resulted in a reduced number of cases available for the education of surgical populaces. Versatile and expanding surgical education solutions are expected to enhance the market growth in the coming years.

Due to technological advancements, 3D printing has gained traction in the medical field in recent years. The applications of 3D printing technology have grown from using 3D models to augment patient education to patient-specific. Moreover, 3D-printed surgical simulators have many advantages over other forms of simulation. Thus, the rising acceptance of 3D printing in surgical simulation contributes to market growth.

Simulation-based healthcare education is a newer modality of training, which was established primarily for patient safety. Rising government initiatives to advance patient safety & patient outcomes in healthcare further support the market growth. For instance, in November 2021, NHS Scotland incorporated physical and digital simulation into its surgical training program to permit trainees to develop vital skills before coming face-to-face with patients.

North America was the dominant regional market in 2024 due to the presence of a large number of key players. Product innovation by market players further facilitated regional market growth. Market players are adopting strategic initiatives, such as partnerships, collaborations, and business expansion to gain deeper market penetration. For instance, in May 2021, PrecisionOS introduced the first fully interactive robotics platform in VR.

Surgical Simulation Market Report Highlights:

• The orthopedic surgery segment dominated the market in 2024 due to the increased prevalence of orthopedic disorders
• However, the reconstructive surgery segment is anticipated to witness the fastest CAGR of 17.20% over the forecast period
• The 3D printing segment dominated the market with the largest share of over 50% in 2024, And the virtual patient simulation segment is expected to grow at the fastest CAGR over the forecast period
• The hospital segment dominated the market in 2024 owing to the collaboration of hospitals with industry partners to develop custom 3D simulator solutions
• For instance, in February 2021, Apollo Hospitals partnered with Anatomiz3D Medtech to create Hospital 3D Printing Labs in India

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Specialty
  • 1.1.2. Technology
  • 1.1.3. End Use
  • 1.1.4. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Specialty Outlook
  • 2.2.2. Technology Outlook
  • 2.2.3. End Use Outlook
• 2.3. Competitive Insights

Chapter 3. Surgical Simulation Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market challenges analysis
• 3.3. Surgical Simulation Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape
• 3.4. COVID 19 Impact Analysis
• 3.5. Case Studies & Insights

Chapter 4. Surgical Simulation Market: Specialty Estimates & Trend Analysis

• 4.1. Specialty Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Surgical Simulation Market by Specialty Outlook
• 4.4. Cardiac Surgery
  • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Gastroenterology
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.6. Neurosurgery
  • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.7. Orthopedic Surgery
  • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.8. Reconstructive Surgery
  • 4.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.9. Oncology Surgery
  • 4.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.10. Transplant
  • 4.10.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.11. Others
  • 4.11.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Surgical Simulation Market: Technology Estimates & Trend Analysis

• 5.1. Technology Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Surgical Simulation Market by Technology Outlook
• 5.4. Virtual Patient Simulation
  • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. 3D Printing
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Surgical Simulation Market: End use Estimates & Trend Analysis

• 6.1. End use Market Share, 2024 & 2030
• 6.2. Segment Dashboard
• 6.3. Surgical Simulation Market by End use Outlook
• 6.4. Academic Institutes
  • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Hospitals
  • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Military Organizations
  • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.7. Research Organizations
  • 6.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Surgical Simulation Market: Regional Estimates & Trend Analysis, By Type

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Denmark
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Norway
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. Notable list of customers
  • 8.3.2. Key Company Market Share/Position Analysis, 2024
  • 8.3.3. Materialise
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Stratasys
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Surgical Science
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Mentice
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Gaumard Scientific
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Simulab Corporation
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. VirtaMed AG
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. 3-Dmed Learning Through Simulation
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Laerdal Medical
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. 3D Systems, Inc.
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Osteo3d
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. AXIAL3D
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
  • 8.3.15. Formlabs
    • 8.3.15.1. Company overview
    • 8.3.15.2. Financial performance
    • 8.3.15.3. Product benchmarking
    • 8.3.15.4. Strategic initiatives
  • 8.3.16. Kyoto Kagaku Co., Ltd.
    • 8.3.16.1. Company overview
    • 8.3.16.2. Financial performance
    • 8.3.16.3. Product benchmarking
    • 8.3.16.4. Strategic initiatives
  • 8.3.17. CAE Inc.
    • 8.3.17.1. Company overview
    • 8.3.17.2. Financial performance
    • 8.3.17.3. Product benchmarking
    • 8.3.17.4. Strategic initiatives